Blockade of immune checkpoints has recently emerged as a novel therapeutic strategy in various tumors. In particular. monoclonal antibodies targeting programmed cell death 1 (PD-1) or its ligand (PD-L1) have been most studied in lung cancer. and PD-1 inhibitors are now established agents in the management of non-small cell lung cancer (NSCLC). https://safeersappliancers.shop/product-category/aeg-dvk6981hb-90cm-angled-chimney-hood-black/